The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study.

scientific article published on 11 November 2015

The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/1756-185X.12782
P698PubMed publication ID26555862

P2093author name stringYang Xin
Xuan Liang
Cao Yongping
Chen Ming
Fan Weimin
Gu Xiaoyuan
Hao Yongqiang
Lin Jianhao
Sun Tiansheng
Sun Tiezheng
Yao Jianhua
P2860cites workA 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA projectQ35249579
Symptomatic slow-acting drugs for osteoarthritis: what are the facts?Q36663201
Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomyQ36837279
Non-surgical treatment of osteoarthritis-related pain in the elderlyQ40504756
The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritisQ41648917
Intra‐articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trialQ57389638
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE systemQ24647595
Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre studyQ33962332
Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbitQ34098373
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysisQ34456671
Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?Q34828779
P433issue3
P921main subjectosteoarthritisQ62736
P304page(s)271-278
P577publication date2015-11-11
P1433published inInternational Journal of Rheumatic DiseasesQ15764244
P1476titleThe efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study.
P478volume19

Reverse relations

cites work (P2860)
Q26740998A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis
Q49922324Osteoarthritis year in review 2017: clinical.
Q49949689Recent advances in hyaluronic acid based therapy for osteoarthritis
Q46820735Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis

Search more.